microdose glp-1 Microdosing How microdosing GLP-1 drugs became

To minimise GLP-1 side effects, these medications are typically prescribed with a process called dose titration starting at a very low dose and gradually increasing it over several weeks to give your body time to adapt

doi: 10.3389/fddev.2024.1456654 Received 28 June 2024 Accepted 14 October 2024 Published 06 November 2024 Volume 4 - 2024 Edited by Rakesh Patel, Shree S K Patel College of Pharmaceutical Education and Research Ganpat University, India Reviewed by Fiona McCartney, University College Dublin, Ireland Samar ISSA, cole de Biologie Industrielle, France Updates Copyright 2024 New, Bogus, Travers, Hahn, Vaiceliunaite, Burnet, Wang and Wen

Predominantly gastrointestinal nausea, diarrhea, vomiting, constipation, and decreased appetite all dose-dependent and most common after a dose or an escalation

Summary: key takeaways GLP-1 receptor agonists are strongly associated with impaired gastric emptying